نتائج البحث - "Christi M.J. Steendam"

المساهمون: Pulmonary Medicine, Medical Oncology, Pharmacy, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE)

المصدر: Lung Cancer, 160, 44-49. Elsevier Ireland Ltd
Lung Cancer, 160, 44-49. ELSEVIER IRELAND LTD

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Erlotinib Hydrochloride/therapeutic use, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Combination therapy, Carcinoma, Non-Small-Cell Lung/drug therapy, Quinazolines/therapeutic use, Taxoids/therapeutic use, EGFR, Non-Small-Cell Lung/drug therapy, Docetaxel, Gastroenterology, Disease-Free Survival, Erlotinib Hydrochloride, SDG 3 - Good Health and Well-being, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Carcinoma, Humans, Progression-free survival, Epidermal growth factor receptor, CANCER PATIENTS, Lung Neoplasms/drug therapy, COMBINATION, neoplasms, SCHEDULE, Docetaxel/therapeutic use, biology, PLASMA, business.industry, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Hazard ratio, CHEMOTHERAPY, medicine.disease, Oncology, Erlotinib, Toxicity, biology.protein, Quinazolines, Taxoids, business, Non-small-cell lung cancer, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f1412cde3a5dc0bde1bb210d253e089
https://doi.org/10.1016/j.lungcan.2021.08.002

View record in OpenAIRE

5

Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI’s: Exploration of efficacy of unselected treatment in a multicenter cohort study

المؤلفون: Christi M.J. Steendam, Sophie M. Ernst, Sushil K. Badrising, Marthe S. Paats, Joachim G.J.V. Aerts, Adrianus J. de Langen, Anne-Marie C. Dingemans

المساهمون: Pulmonary Medicine

المصدر: Lung Cancer, 181:107248. Elsevier Ireland Ltd

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Cancer Research, SDG 3 - Good Health and Well-being, Oncology

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb57b730c4db71ca2a8886c943affe95
https://doi.org/10.1016/j.lungcan.2023.107248

View record in OpenAIRE

6

Influence of Cow’s Milk and Esomeprazole on the Absorption of Erlotinib: A Randomized, Crossover Pharmacokinetic Study in Lung Cancer Patients

المؤلفون: Kersten D. Landa, Esther Oomen-de Hoop, Marthe S. Paats, G.D. Marijn Veerman, Ron H.J. Mathijssen, Robert Peric, Anne-Marie C. Dingemans, Teun van Gelder, Cor van der Leest, Suzanna D. Broerse, Stijn L.W. Koolen, Hugo B. Rutten, Christi M.J. Steendam, Huub Belderbos, Koen G. A. M. Hussaarts, Roelof W F van Leeuwen, Joachim G.J.V. Aerts

المساهمون: Medical Oncology, Pulmonary Medicine, Pharmacy

المصدر: Clinical Pharmacokinetics
Clinical Pharmacokinetics, 60(1), 69-77. Adis

مصطلحات موضوعية: Male, medicine.medical_specialty, Lung Neoplasms, Cmax, Gastroenterology, Esomeprazole, Erlotinib Hydrochloride, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Pharmacokinetics, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Animals, Humans, Drug Interactions, heterocyclic compounds, Pharmacology (medical), Original Research Article, Lung cancer, neoplasms, Aged, 030304 developmental biology, Pharmacology, 0303 health sciences, Cross-Over Studies, business.industry, Area under the curve, Proton Pump Inhibitors, Middle Aged, medicine.disease, Crossover study, respiratory tract diseases, Milk, 030220 oncology & carcinogenesis, Concomitant, Female, Erlotinib, business, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e790cd1b0f87889be0200663d1844124
https://doi.org/10.1007/s40262-020-00910-1

View record in OpenAIRE

7

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA

المؤلفون: Manouk K. Bos, Kazem Nasserinejad, Maurice P. H. M. Jansen, Christi M.J. Steendam, Lindsay Angus, Peggy N. Atmodimedjo, Evert Jonge, Winand N. M. Dinjens, Ron H. N. Schaik, Marzia Del Re, Hendrikus J. Dubbink, Stefan Sleijfer, John W. M. Martens

المساهمون: Medical Oncology, Hematology, Pathology, Clinical Chemistry

المصدر: Molecular Oncology, Vol 15, Iss 1, Pp 57-66 (2021)
Molecular Oncology, 15(1), 57-66. John Wiley & Sons Ltd.

مصطلحات موضوعية: unit of measurement, 0301 basic medicine, Cancer Research, Mutant, next‐generation sequencing, Computational biology, Biology, DNA sequencing, Circulating Tumor DNA, Cohort Studies, 03 medical and health sciences, chemistry.chemical_compound, Deming regression, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Gene Frequency, Genetics, cancer, Molecule, Humans, circulating tumor DNA, digital droplet PCR, liquid biopsy, next-generation sequencing, High-Throughput Nucleotide Sequencing, Mutation, Regression Analysis, Liquid biopsy, RC254-282, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, Variant allele, 030104 developmental biology, Oncology, chemistry, Circulating tumor DNA, 030220 oncology & carcinogenesis, Molecular Medicine, DNA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::818d730242e4bdd3fb770628baad22d9
https://pubmed.ncbi.nlm.nih.gov/34599543

View record in OpenAIRE

8

P24.08 Lung Cancer Diagnosis in Absence of Adequate Tissue Molecular Analysis in Metastatic Disease by NGS Analysis of Plasma cfDNA

المؤلفون: E. de Jonge, Daphne W. Dumoulin, R.H.N. van Schaik, K. Van Loenhout, W. Hanselaar, J. Von Der Thüsen, A-M.C. Dingemans, Peggy N. Atmodimedjo, Joachim G.J.V. Aerts, C. van der Leest, S. Van'T Westeinde, Christi M.J. Steendam, H.J. Dubbink

المصدر: Journal of Thoracic Oncology. 16:S1034

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, Internal medicine, medicine, Disease, business, Lung cancer, medicine.disease, Plasma.cfDNA, Molecular analysis

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5409d38a57d399f7b5afefde2deaca19
https://doi.org/10.1016/j.jtho.2021.08.373

View record in OpenAIRE

9

1343P Correlating osimertinib and erlotinib pharmacokinetics with efficacy and toxicity in EGFR-mutated NSCLC patients (START-TKI study)

المؤلفون: Stijn L.W. Koolen, G.D.M. Veerman, Ron H.J. Mathijssen, Joachim G.J.V. Aerts, Christi M.J. Steendam, E. Oomen-de Hoop, A-M.C. Dingemans

المصدر: Annals of Oncology. 31:S861-S862

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Pharmacokinetics, business.industry, Internal medicine, Toxicity, medicine, Osimertinib, Hematology, Erlotinib, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a7d8876b2dca6d90ada77b24543878e1
https://doi.org/10.1016/j.annonc.2020.08.1657

View record in OpenAIRE

10

Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment

المؤلفون: Giuliana Restante, Eleonora Rofi, Christi M.J. Steendam, Marzia Del Re, Marcello Tiseo, Francesca Mazzoni, Antonio Frassoldati, Romano Danesi, Alfredo Falcone, Paola Bordi, Enrico Vasile, Francesco Di Costanzo, Antonio Chella, Riccardo Morganti, Lorenzo Belluomini, Ron H.N. van Schaik, Iacopo Petrini

المساهمون: Clinical Chemistry, Pulmonary Medicine

المصدر: Oncotarget
Oncotarget, 8(49), 86056-86065. Impact Journals LLC

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07fb39ab9ebacd18acf4ce527f643e05
https://doi.org/10.18632/oncotarget.20947

View record in OpenAIRE

11

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer

المؤلفون: Christi M.J. Steendam, Winand N.M. Dinjens, Stijn L.W. Koolen, Melinda A. Pruis, Peggy N. Atmodimedjo, Marthe S. Paats, David C Y Yick, Jan H. von der Thüsen, Anne-Marie C. Dingemans, Ron H.N. van Schaik, Ron H.J. Mathijssen, Joachim G.J.V. Aerts, G.D. Marijn Veerman, Cor van der Leest, Hendrikus J. Dubbink, Esther Oomen-de Hoop

المساهمون: Pulmonary Medicine, Medical Oncology, Pathology, Hematology, Clinical Chemistry, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Pulmonologie, MUMC+: MA Med Staf Spec Longziekten (9)

المصدر: Cancers
Volume 12
Issue 11
Cancers, Vol 12, Iss 3179, p 3179 (2020)
Cancers, 12(11):3179, 1-17. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 12(11):3179. Multidisciplinary Digital Publishing Institute (MDPI)

مصطلحات موضوعية: OSIMERTINIB, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.drug_class, EGFR, ERLOTINIB, PROGRESSION, NSCLC, plasma conversion, lcsh:RC254-282, Article, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Pharmacokinetics, Internal medicine, Medicine, CHINESE PATIENTS, Osimertinib, TP53, Epidermal growth factor receptor, cfDNA, Lung cancer, biology, MUTATIONS, business.industry, Kinase, TP53 mutation, MASS-SPECTROMETRY, QUANTIFICATION, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, TKI, respiratory tract diseases, 030104 developmental biology, T790M mutation, 030220 oncology & carcinogenesis, Concomitant, biology.protein, Erlotinib, TYROSINE KINASE INHIBITOR, business, pharmacokinetics, medicine.drug